1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Adenoma, Basophil: new trials by email Literature Review of Adenoma, Basophil trials Research Report on Adenoma, Basophil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia gamma-secretase/Notch signalling pathway inhibitor RO4929097, diagnostic laboratory biomarker analysis, pharmacological study - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma | Phase 1 | Terminated | National Cancer Institute (NCI) | 129 | 2010-03-01 | 2014-11-05 |
Adenoma, Acidophil (1) · Adenoma, Chromophobe (1) · Astrocytoma (1) · Burkitt Lymphoma (1) · Choroid Plexus Neoplasms (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Familial ependymoma (1) · Leukemia, Large Granular Lymphocytic (1) · Lymphoma, Large-Cell, Anaplastic (1) · Medulloblastoma (1) · Oligodendroglioma (1) · Optic Nerve Glioma (1) · Pituitary Neoplasms (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Adenoma (1) · Brain Diseases (1) · Brain Neoplasms (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Cerebral Ventricle Neoplasms (1) · Cranial Nerve Diseases (1) · Cranial Nerve Neoplasms (1) · DNA Virus Infections (1) · Disease Attributes (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Epstein-Barr Virus Infections (1) · Eye Diseases (1) · Glioma (1)
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1) · Calcium Dobesilate (1) · Dexamethasone (1)
National Cancer Institute (NCI) (1)
Canada (1) · United States (1)
Najat Daw (1)
U01CA097452 (1)